216 related articles for article (PubMed ID: 24469344)
1. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
Buszman PP; Milewski K; Pająk J; Jelonek M; Orlik B; Krauze A; Gwiazdowska-Nowotka B; Wojakowski W; Tellez A; Granada JF; Buszman PE
EuroIntervention; 2014 Oct; 10(6):724-31. PubMed ID: 24469344
[TBL] [Abstract][Full Text] [Related]
2. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
[TBL] [Abstract][Full Text] [Related]
3. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
[TBL] [Abstract][Full Text] [Related]
4. Experimental evaluation of efficacy and healing response of everolimus-eluting stents in the familial hypercholesterolemic swine model: a comparative study of bioabsorbable versus durable polymer stent platforms.
Tellez A; Seifert PS; Donskoy E; Sushkova N; Pennington DE; Milewski K; Krueger CG; Kaluza GL; Eppihimer MJ; Huibregtse BA; Dawkins KD; Granada JF
Coron Artery Dis; 2014 May; 25(3):198-207. PubMed ID: 24642807
[TBL] [Abstract][Full Text] [Related]
5. Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
Buszman PP; Tellez A; Afari M; Cheng Y; Conditt GB; McGregor JC; Milewski K; Stenoien M; Kaluza GL; Granada JF
EuroIntervention; 2013 Aug; 9(4):510-6. PubMed ID: 23965356
[TBL] [Abstract][Full Text] [Related]
6. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
[TBL] [Abstract][Full Text] [Related]
7. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
8. Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.
Sheehy A; Hsu S; Bouchard A; Lema P; Savard C; Guy LG; Tai J; Polyakov I
Cardiovasc Diabetol; 2012 Jun; 11():75. PubMed ID: 22716997
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent-mediated delivery of everolimus.
Zhao HQ; Nikanorov A; Virmani R; Schwartz LB
J Vasc Surg; 2012 Dec; 56(6):1680-8. PubMed ID: 22841285
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent vascular response following delivery of sirolimus via fast releasing, biodegradable polymer stent matrix: an experimental study in the porcine coronary model of restenosis.
Buszman PP; Orlik B; Pająk J; Jelonek M; Krauze A; Janas A; Legutko J; Wojakowski W; Buszman PE; Milewski K
Kardiol Pol; 2015; 73(10):916-23. PubMed ID: 25985728
[TBL] [Abstract][Full Text] [Related]
11. Investigation of long-term implantation of BuMA stent in a porcine coronary model.
Chen M; Wang XG; Zheng B; Peng HY; Zhang XY; Zhang B; Huo Y
Chin Med J (Engl); 2012 Nov; 125(22):4083-7. PubMed ID: 23158147
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study.
Simsek C; Räber L; Magro M; Boersma E; Onuma Y; Stefanini GG; Zanchin T; Kalesan B; Wenaweser P; Jüni P; van Geuns RJ; van Domburg RT; Windecker S; Serruys PW
Int J Cardiol; 2013 Dec; 170(1):36-42. PubMed ID: 24196314
[TBL] [Abstract][Full Text] [Related]
14. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model.
Nakazawa G; Shinke T; Ijichi T; Matsumoto D; Otake H; Torii S; Hiranuma N; Ohsue T; Otsuka F; Shite J; Hirata K; Ikari Y
EuroIntervention; 2014 Oct; 10(6):717-23. PubMed ID: 25330504
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model.
Cilingiroglu M; Elliott J; Sangi P; Matthews H; Tio F; Trauthen B; Elicker J; Bailey SR
EuroIntervention; 2009 Jan; 4(4):534-41. PubMed ID: 19284078
[TBL] [Abstract][Full Text] [Related]
16. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
[TBL] [Abstract][Full Text] [Related]
17. Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model.
Milewski K; Zurakowski A; Pajak J; Liszka L; Debinski M; Buszman PP; Samra MA; Dominek P; Aboodi MS; Kaluza GL; Buszman P
Cardiovasc Revasc Med; 2011; 12(2):82-9. PubMed ID: 21421185
[TBL] [Abstract][Full Text] [Related]
18. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
Sperling C; Waliszewski MW; Kherad B; Krackhardt F
Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
[TBL] [Abstract][Full Text] [Related]
19. Impact of bioresorbable versus permanent polymer on longterm vessel wall inflammation and healing: a comparative drug-eluting stent experimental study.
Wilson GJ; McGregor J; Conditt G; Shibuya M; Sushkova N; Eppihimer MJ; Hawley SP; Rouselle SD; Huibregtse BA; Dawkins KD; Granada JF
EuroIntervention; 2018 Feb; 13(14):1670-1679. PubMed ID: 28846542
[TBL] [Abstract][Full Text] [Related]
20. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.
Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R
Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
